Johnson & Johnson

OncoDaily

News Feed Opinion Career Insight Dialogues Blog Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

Johnson & Johnson

Jul 7, 2024, 18:19 | Insight

Shahrin Ahmed: Efficacy of CARVYKTI in multiple myeloma

Shahrin Ahmed, Medical Specialist at the Canadian Cancer Society, shared on X: "The Phase III…

Jun 21, 2024, 13:43 | Insight

Luca Dezzani: We are requesting approval from the U.S. FDA EGFR-mutated NSCLC therapy

Luca Dezzani, Vice President of US Oncology Medical Affairs at Johnson & Johnson, shared a…

Mar 11, 2024, 00:11 | Career

Mary Kate Weber: I've stepped into the role of Associate Director, Patient and Caregiver Solutions - Oncology within the PECS organization at Johnson & Johnson!

Mary Kate Weber, Associate Director, Patient & Caregiver Solutions - Oncology at Johnson & Johnson,…

Nov 9, 2023, 18:59 | Drugs

Najat Khan: Lots of buzz about the future of drug discovery

Najat Khan, Chief Data Science Officer & SVP/Global Head at Johnson & Johnson, made the…

Oct 7, 2023, 19:42 | Blog

Najat Khan: The results of the world’s largest blood biomarker study have been published in Nature, opening up new possibilities for scientific research.

Najat Khan, Chief Data Science Officer & SVP/Global Head, Strategy, Portfolio, Ops, R&D, J&J at…

Sep 15, 2023, 18:40 | Blog

Warm welcome and congratulations to CancerX’s inaugural steering committee, which provides an additional layer of governance within our public-private partnership model. - CancerX Moonshot

All: 6 Posts: 1 - 100